SAN DIEGO, October 8 /PRNewswire/ --

- Findings Confirm Potency of Poly-ICR as Vaccine Adjuvant

Nventa Biopharmaceuticals Corporation (TSX: NVN) today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly Arginine (Poly-ICR), at the World Vaccine Congress 2008 in Lyon, France. Study results demonstrated Poly-ICR to be a potent vaccine adjuvant targeting the Toll-like Receptor 3 (TLR3) pathway. Data showed that Poly-ICR, in combination with model antigens, elicits strong anti-target antibody and CD8 T-cell immune responses. These findings demonstrate the versatility of Poly-ICR, suggesting that the compound may possess broad potential for use in both therapeutic and prophylactic vaccines.

LONDON, October 8 /PRNewswire/ --

- Video Sharing Rises as Internet Makes Celeb Status More Achievable

Arguments over the remote control may be a thing of the past as more than half of Britons now use social media to share their lives online more than they watch television, according to new research from Flip Video.

More than half (58%) of 18 to 24 year olds visit a social networking site every day with 42% of 25 to 34 year olds admitting the same frequency. TV is now really taking a back seat for this audience, with 61% of 18 to 24 year olds and over half of 25 to 34 year olds spending more time online than watching TV.

NEW YORK, October 8 /PRNewswire/ --

- Agreement Follows Recent Grant by Intellect of License to Wyeth (NYSE: WYE) and Elan Pharma International Ltd.

Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), announced today that it has entered into an Option Agreement with a top-tier global pharmaceutical company regarding the right to purchase a license to certain of Intellect's patents and patent applications related to antibodies and methods of treatment for Alzheimer's disease.

COSTA MESA, California, October 8 /PRNewswire/ --

Tickets.com, a leading worldwide provider of integrated ticketing solutions, has launched ProVenue(R), its new, innovative full-service ticketing platform. Developed and rigorously tested by Tickets.com, ProVenue is a turnkey solution and the industry's most technologically advanced and sophisticated ticketing services product. It officially went live on September 13, 2008, flawlessly enabling the inaugural on-sale day for fifteen major shows comprising the opening season of the newly renovated Wellmont Theatre in Montclair, NJ.

PARIS, October 8 /PRNewswire/ -- After 9 months of intensive beta testing using a pool of 9,000 servers created by over 4,000 individual customers, Gandi.net, the largest ICANN-accredited registrar in France, announces the grand opening of its unparalleled hosting service.

ZUG, Switzerland, October 8 /PRNewswire/ --

- Naspers - Acquisition of the Auction Web Site vatera.hu

MIH Internet Europe is pleased to announce its acquisition of vatera.hu, Hungary's leading auction Web site. MIH Internet Europe, a subsidiary of the South African print and online media company Naspers (JSE: NPN) now holds 100% of the share capital of vatera.hu.